22/05/2018 - 06:35

MGC to use Malta as springboard into EU cannabis market

22/05/2018 - 06:35

Bookmark

Save articles for future reference.

ASX-listed MGC Pharmaceuticals’ proposed medical marijuana facility in Malta looks set to go ahead after landmark laws legalising medicinal cannabis were passed by the Southern European nation’s Parliament. MGC is now on the verge of official approval for its 4,000 square metre facility that it aims to use to launch into the rapidly expanding EU medical marijuana market.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options